Ulla Wartiovaara-Kautto

E-postadressulla.m.wartiovaara-kauttohelsinkifi

Finland

Forskningsoutput per år

Vetenskapsgrenar

3122 Cancersjukdomar

51 Artikel
6 Översiktsartikel
3 Brev
1 Kapitel
Mer
- 1 Mötesabstrakt
- 1 Kommentar/debatt

Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review
Ukonmaanaho, E.-M., Dell'Anna, S., Hakonen, A., Wartiovaara-Kautto, U., Kakko, S., Rab, M. A. E., van Oirschot, B., Kraatari-Tiri, M., van Wijk, R. & Rahikkala, E., maj 2024, I: British Journal of Haematology. 204, 5, s. 2040-2048 9 s.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång
Fil
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
Baliakas, P., Tesi, B., Cammenga, J., Stray-Pedersen, A., Jahnukainen, K., Andersen, M. K., Ågerstam, H., Creignou, M., Dybedal, I., Raaschou-Jensen, K., Grønbæk, K., Kilpivaara, O., Hellström Lindberg, E. & Wartiovaara-Kautto, U., aug. 2024, I: Hemasphere. 8, 8, 5 s., e145.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång
Fil
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22⁺ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia
The Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL), Chevallier, P., Leguay, T., Delord, M., Wartiovaara-Kautto, U. & Rousselot, P., 20 dec. 2024, I: Journal of Clinical Oncology. 42, 36, s. 4327-4341 17 s.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
NFKB1-geenin variantit altistavat nekrotisoivalle faskiitille
Nurmi, K., Silventoinen, K., Keskitalo, S., Rajamäki, K., Kouri, V.-P., Kinnunen, M., Jalil, S., Maldonado, R., Wartiovaara, K., Nievas, E. I., Denita-Juárez, S. P., Duncan, C. J. A., Kuismin, O., Saarela, J., Romo, I., Martelius, T., Parantainen, J., Beklen, A., Bilicka, M. & Matikainen, S. & 12 andra, Nordström, D. C., Kaustio, M., Wartiovaara-Kautto, U., Kilpivaara, O., Klein, C., Hauck, F., Jahkola, T., Hautala, T., Varjosalo, M., Goncalo, B., Seppänen, M. R. J. & Eklund, K. K., 2024, I: Duodecim. 140, 12, 1 s.
Forskningsoutput: Tidskriftsbidrag › Kommentar/debatt › Professionell
Subsequent malignant neoplasms after primary hematological malignancy in adult patients
Rönkkö, R. M., Nevala, A. O., Pitkäniemi, J. M., Wartiovaara-Kautto, U. M. & Malila, N. K., 15 sep. 2024, I: International Journal of Cancer. 155, 6, s. 1007-1013 7 s.
Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Öppen tillgång
Fil

1 Aktiv

Syöpäsäätiö_2025_Wartiovaara-Kautto Ulla
Wartiovaara-Kautto, U. (Projektledare)
Syöpäsäätiö sr Cancerstiftelsen sr
01/01/2025 → 31/12/2025
Projekt: Stiftelser och fonder

Ulla Wartiovaara-Kautto

Personlig profil

Vetenskapsgrenar

Internationellt och inhemskt samarbete

Fördjupning

Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review

How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22⁺ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia

NFKB1-geenin variantit altistavat nekrotisoivalle faskiitille

Subsequent malignant neoplasms after primary hematological malignancy in adult patients

Syöpäsäätiö_2025_Wartiovaara-Kautto Ulla

Ulla Wartiovaara-Kautto

Personlig profil

Vetenskapsgrenar

Internationellt och inhemskt samarbete

Publikationer

Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review

How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia

NFKB1-geenin variantit altistavat nekrotisoivalle faskiitille

Subsequent malignant neoplasms after primary hematological malignancy in adult patients

Projekter

Syöpäsäätiö_2025_Wartiovaara-Kautto Ulla

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22⁺ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia